 | • レポートコード：MRC2-11QY11732 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は自律神経失調症のグローバル市場について調査・分析したレポートです。種類別（一次自律神経失調症、二次自律神経失調症）市場規模、用途別（病院・クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別自律神経失調症の競争状況、市場シェア ・世界の自律神経失調症市場：種類別市場規模 2015年-2020年（一次自律神経失調症、二次自律神経失調症） ・世界の自律神経失調症市場：種類別市場規模予測 2021年-2026年（一次自律神経失調症、二次自律神経失調症） ・世界の自律神経失調症市場：用途別市場規模 2015年-2020年（病院・クリニック、その他） ・世界の自律神経失調症市場：用途別市場規模予測 2021年-2026年（病院・クリニック、その他） ・北米の自律神経失調症市場分析：米国、カナダ ・ヨーロッパの自律神経失調症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの自律神経失調症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の自律神経失調症市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの自律神経失調症市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Novartis、Pfizer、Celltex Therpeutics、Shire、Santhera Pharmaceuticals、Theravance Biopharma、Lundbeck、Axsome Therpeutics、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Dysautonomia (Autonomic Dysfunction) is a disorder of autonomic nervous system.
Factors driving global demand for Dysautonomia are increasing awareness amongst people, government initiatives and increased diagnosis.
Market Analysis and Insights: Global Dysautonomia Market
The global Dysautonomia market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Dysautonomia Scope and Market Size
Dysautonomia market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Dysautonomia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Novartis
Pfizer
Celltex Therpeutics
Shire
Santhera Pharmaceuticals
Theravance Biopharma
Lundbeck
Axsome Therpeutics
Merck
Market segment by Type, the product can be split into
Primary Dysautonomia
Secondary Dysautonomia
Market segment by Application, split into
Hospitals and Clinics
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Dysautonomia Revenue
1.4 Market by Type
1.4.1 Global Dysautonomia Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Primary Dysautonomia
1.4.3 Secondary Dysautonomia
1.5 Market by Application
1.5.1 Global Dysautonomia Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Dysautonomia Market Perspective (2015-2026)
2.2 Global Dysautonomia Growth Trends by Regions
2.2.1 Dysautonomia Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Dysautonomia Historic Market Share by Regions (2015-2020)
2.2.3 Dysautonomia Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Dysautonomia Market Growth Strategy
2.3.6 Primary Interviews with Key Dysautonomia Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Dysautonomia Players by Market Size
3.1.1 Global Top Dysautonomia Players by Revenue (2015-2020)
3.1.2 Global Dysautonomia Revenue Market Share by Players (2015-2020)
3.1.3 Global Dysautonomia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Dysautonomia Market Concentration Ratio
3.2.1 Global Dysautonomia Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Dysautonomia Revenue in 2019
3.3 Dysautonomia Key Players Head office and Area Served
3.4 Key Players Dysautonomia Product Solution and Service
3.5 Date of Enter into Dysautonomia Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Dysautonomia Historic Market Size by Type (2015-2020)
4.2 Global Dysautonomia Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Dysautonomia Market Size by Application (2015-2020)
5.2 Global Dysautonomia Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Dysautonomia Market Size (2015-2020)
6.2 Dysautonomia Key Players in North America (2019-2020)
6.3 North America Dysautonomia Market Size by Type (2015-2020)
6.4 North America Dysautonomia Market Size by Application (2015-2020)
7 Europe
7.1 Europe Dysautonomia Market Size (2015-2020)
7.2 Dysautonomia Key Players in Europe (2019-2020)
7.3 Europe Dysautonomia Market Size by Type (2015-2020)
7.4 Europe Dysautonomia Market Size by Application (2015-2020)
8 China
8.1 China Dysautonomia Market Size (2015-2020)
8.2 Dysautonomia Key Players in China (2019-2020)
8.3 China Dysautonomia Market Size by Type (2015-2020)
8.4 China Dysautonomia Market Size by Application (2015-2020)
9 Japan
9.1 Japan Dysautonomia Market Size (2015-2020)
9.2 Dysautonomia Key Players in Japan (2019-2020)
9.3 Japan Dysautonomia Market Size by Type (2015-2020)
9.4 Japan Dysautonomia Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Dysautonomia Market Size (2015-2020)
10.2 Dysautonomia Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Dysautonomia Market Size by Type (2015-2020)
10.4 Southeast Asia Dysautonomia Market Size by Application (2015-2020)
11 India
11.1 India Dysautonomia Market Size (2015-2020)
11.2 Dysautonomia Key Players in India (2019-2020)
11.3 India Dysautonomia Market Size by Type (2015-2020)
11.4 India Dysautonomia Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Dysautonomia Market Size (2015-2020)
12.2 Dysautonomia Key Players in Central & South America (2019-2020)
12.3 Central & South America Dysautonomia Market Size by Type (2015-2020)
12.4 Central & South America Dysautonomia Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Dysautonomia Introduction
13.1.4 Novartis Revenue in Dysautonomia Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Dysautonomia Introduction
13.2.4 Pfizer Revenue in Dysautonomia Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Celltex Therpeutics
13.3.1 Celltex Therpeutics Company Details
13.3.2 Celltex Therpeutics Business Overview
13.3.3 Celltex Therpeutics Dysautonomia Introduction
13.3.4 Celltex Therpeutics Revenue in Dysautonomia Business (2015-2020)
13.3.5 Celltex Therpeutics Recent Development
13.4 Shire
13.4.1 Shire Company Details
13.4.2 Shire Business Overview
13.4.3 Shire Dysautonomia Introduction
13.4.4 Shire Revenue in Dysautonomia Business (2015-2020)
13.4.5 Shire Recent Development
13.5 Santhera Pharmaceuticals
13.5.1 Santhera Pharmaceuticals Company Details
13.5.2 Santhera Pharmaceuticals Business Overview
13.5.3 Santhera Pharmaceuticals Dysautonomia Introduction
13.5.4 Santhera Pharmaceuticals Revenue in Dysautonomia Business (2015-2020)
13.5.5 Santhera Pharmaceuticals Recent Development
13.6 Theravance Biopharma
13.6.1 Theravance Biopharma Company Details
13.6.2 Theravance Biopharma Business Overview
13.6.3 Theravance Biopharma Dysautonomia Introduction
13.6.4 Theravance Biopharma Revenue in Dysautonomia Business (2015-2020)
13.6.5 Theravance Biopharma Recent Development
13.7 Lundbeck
13.7.1 Lundbeck Company Details
13.7.2 Lundbeck Business Overview
13.7.3 Lundbeck Dysautonomia Introduction
13.7.4 Lundbeck Revenue in Dysautonomia Business (2015-2020)
13.7.5 Lundbeck Recent Development
13.8 Axsome Therpeutics
13.8.1 Axsome Therpeutics Company Details
13.8.2 Axsome Therpeutics Business Overview
13.8.3 Axsome Therpeutics Dysautonomia Introduction
13.8.4 Axsome Therpeutics Revenue in Dysautonomia Business (2015-2020)
13.8.5 Axsome Therpeutics Recent Development
13.9 Merck
13.9.1 Merck Company Details
13.9.2 Merck Business Overview
13.9.3 Merck Dysautonomia Introduction
13.9.4 Merck Revenue in Dysautonomia Business (2015-2020)
13.9.5 Merck Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Dysautonomia Key Market Segments
Table 2. Key Players Covered: Ranking by Dysautonomia Revenue
Table 3. Ranking of Global Top Dysautonomia Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Dysautonomia Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Primary Dysautonomia
Table 6. Key Players of Secondary Dysautonomia
Table 7. Global Dysautonomia Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Dysautonomia Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Dysautonomia Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Dysautonomia Market Share by Regions (2015-2020)
Table 11. Global Dysautonomia Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Dysautonomia Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Dysautonomia Market Growth Strategy
Table 17. Main Points Interviewed from Key Dysautonomia Players
Table 18. Global Dysautonomia Revenue by Players (2015-2020) (Million US$)
Table 19. Global Dysautonomia Market Share by Players (2015-2020)
Table 20. Global Top Dysautonomia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dysautonomia as of 2019)
Table 21. Global Dysautonomia by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Dysautonomia Product Solution and Service
Table 24. Date of Enter into Dysautonomia Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Dysautonomia Market Size by Type (2015-2020) (Million US$)
Table 27. Global Dysautonomia Market Size Share by Type (2015-2020)
Table 28. Global Dysautonomia Revenue Market Share by Type (2021-2026)
Table 29. Global Dysautonomia Market Size Share by Application (2015-2020)
Table 30. Global Dysautonomia Market Size by Application (2015-2020) (Million US$)
Table 31. Global Dysautonomia Market Size Share by Application (2021-2026)
Table 32. North America Key Players Dysautonomia Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Dysautonomia Market Share (2019-2020)
Table 34. North America Dysautonomia Market Size by Type (2015-2020) (Million US$)
Table 35. North America Dysautonomia Market Share by Type (2015-2020)
Table 36. North America Dysautonomia Market Size by Application (2015-2020) (Million US$)
Table 37. North America Dysautonomia Market Share by Application (2015-2020)
Table 38. Europe Key Players Dysautonomia Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Dysautonomia Market Share (2019-2020)
Table 40. Europe Dysautonomia Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Dysautonomia Market Share by Type (2015-2020)
Table 42. Europe Dysautonomia Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Dysautonomia Market Share by Application (2015-2020)
Table 44. China Key Players Dysautonomia Revenue (2019-2020) (Million US$)
Table 45. China Key Players Dysautonomia Market Share (2019-2020)
Table 46. China Dysautonomia Market Size by Type (2015-2020) (Million US$)
Table 47. China Dysautonomia Market Share by Type (2015-2020)
Table 48. China Dysautonomia Market Size by Application (2015-2020) (Million US$)
Table 49. China Dysautonomia Market Share by Application (2015-2020)
Table 50. Japan Key Players Dysautonomia Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Dysautonomia Market Share (2019-2020)
Table 52. Japan Dysautonomia Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Dysautonomia Market Share by Type (2015-2020)
Table 54. Japan Dysautonomia Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Dysautonomia Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Dysautonomia Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Dysautonomia Market Share (2019-2020)
Table 58. Southeast Asia Dysautonomia Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Dysautonomia Market Share by Type (2015-2020)
Table 60. Southeast Asia Dysautonomia Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Dysautonomia Market Share by Application (2015-2020)
Table 62. India Key Players Dysautonomia Revenue (2019-2020) (Million US$)
Table 63. India Key Players Dysautonomia Market Share (2019-2020)
Table 64. India Dysautonomia Market Size by Type (2015-2020) (Million US$)
Table 65. India Dysautonomia Market Share by Type (2015-2020)
Table 66. India Dysautonomia Market Size by Application (2015-2020) (Million US$)
Table 67. India Dysautonomia Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Dysautonomia Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Dysautonomia Market Share (2019-2020)
Table 70. Central & South America Dysautonomia Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Dysautonomia Market Share by Type (2015-2020)
Table 72. Central & South America Dysautonomia Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Dysautonomia Market Share by Application (2015-2020)
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Product
Table 77. Novartis Revenue in Dysautonomia Business (2015-2020) (Million US$)
Table 78. Novartis Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Dysautonomia Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. Celltex Therpeutics Company Details
Table 85. Celltex Therpeutics Business Overview
Table 86. Celltex Therpeutics Product
Table 87. Celltex Therpeutics Revenue in Dysautonomia Business (2015-2020) (Million US$)
Table 88. Celltex Therpeutics Recent Development
Table 89. Shire Company Details
Table 90. Shire Business Overview
Table 91. Shire Product
Table 92. Shire Revenue in Dysautonomia Business (2015-2020) (Million US$)
Table 93. Shire Recent Development
Table 94. Santhera Pharmaceuticals Company Details
Table 95. Santhera Pharmaceuticals Business Overview
Table 96. Santhera Pharmaceuticals Product
Table 97. Santhera Pharmaceuticals Revenue in Dysautonomia Business (2015-2020) (Million US$)
Table 98. Santhera Pharmaceuticals Recent Development
Table 99. Theravance Biopharma Company Details
Table 100. Theravance Biopharma Business Overview
Table 101. Theravance Biopharma Product
Table 102. Theravance Biopharma Revenue in Dysautonomia Business (2015-2020) (Million US$)
Table 103. Theravance Biopharma Recent Development
Table 104. Lundbeck Company Details
Table 105. Lundbeck Business Overview
Table 106. Lundbeck Product
Table 107. Lundbeck Revenue in Dysautonomia Business (2015-2020) (Million US$)
Table 108. Lundbeck Recent Development
Table 109. Axsome Therpeutics Business Overview
Table 110. Axsome Therpeutics Product
Table 111. Axsome Therpeutics Company Details
Table 112. Axsome Therpeutics Revenue in Dysautonomia Business (2015-2020) (Million US$)
Table 113. Axsome Therpeutics Recent Development
Table 114. Merck Company Details
Table 115. Merck Business Overview
Table 116. Merck Product
Table 117. Merck Revenue in Dysautonomia Business (2015-2020) (Million US$)
Table 118. Merck Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dysautonomia Market Share by Type: 2020 VS 2026
Figure 2. Primary Dysautonomia Features
Figure 3. Secondary Dysautonomia Features
Figure 4. Global Dysautonomia Market Share by Application: 2020 VS 2026
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Others Case Studies
Figure 7. Dysautonomia Report Years Considered
Figure 8. Global Dysautonomia Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Dysautonomia Market Share by Regions: 2020 VS 2026
Figure 10. Global Dysautonomia Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Dysautonomia Market Share by Players in 2019
Figure 13. Global Top Dysautonomia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dysautonomia as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Dysautonomia Revenue in 2019
Figure 15. North America Dysautonomia Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Dysautonomia Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Dysautonomia Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Dysautonomia Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Dysautonomia Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Dysautonomia Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Dysautonomia Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
二次性副甲状腺機能亢進症治療の世界市場（～2026年） Secondary hyperparathyroidism refers to the excessive secretion of parathyroid hormone by the parathyroid glands in response to hypocalcemia and associated hyperplasia of the glands. In the treatment of secondary hyperparathyroidism due to chronic kidney disease on dialysis calcimimetics do not appe…- 二次電池リサイクルの世界市場（～2026年） Battery recycling is a process that helps reduce the number of batteries being disposed as municipal solid waste. Secondary batteries should be disposed properly, as they comprise several heavy metals and toxic chemicals. A key factor driving the growth of the market is the self-sustainability of ba…
- 二次アルカンスルホン酸塩の世界市場（～2026年） Secondary Alkane Sulfonate (SAS) is an anionic surfactant, also called paraffine sulfonate. It was synthesized for the first time in 1940 and has been used as surfactant since the 1960ies. SAS is one of the major anionic surfactants used in the market of dishwashing, laundry and cleaning products. S…
- 二次アルカンスルホン酸塩（SAS）の世界市場（～2026年） Market Analysis and Insights: Global Secondary Alkane Sulfonate (SAS) Market The global Secondary Alkane Sulfonate (SAS) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Secondary Alkane Sulfonate (SAS) Scope and Market…
- 二次微量栄養素の世界市場（～2026年） Secondary macronutrients are often used in gardening to help plants that are in distress while boosting their overall health and growth. The main secondary macronutrients include magnesium, sulfur, and calcium. Asia Pacific is projected to be fastest-growing market for secondary macronutrients over …